Cargando…
ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis
Metastasis is the leading cause of death in cancer patients due to the difficulty of controlling this complex process. MicroRNAs (miRNA), endogenous noncoding short RNAs with important biological and pathological functions, may play a regulatory role during cancer metastasis, but this role has yet t...
Autores principales: | Chiu, Kuo-Liang, Kuo, Ting-Ting, Kuok, Qian-Yu, Lin, Yu-Sen, Hua, Chung-Hung, Lin, Chen-Yuan, Su, Pei-Yuan, Lai, Liang-Chuan, Sher, Yuh-Pyng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639752/ https://www.ncbi.nlm.nih.gov/pubmed/26553452 http://dx.doi.org/10.1038/srep16426 |
Ejemplares similares
-
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2017) -
ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells
por: Sher, Yuh-Pyng, et al.
Publicado: (2014) -
An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases
por: Chou, Cheng-Wei, et al.
Publicado: (2020) -
Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment
por: Wong, Sze‐Ching, et al.
Publicado: (2023) -
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT
por: Lin, Chen-Yuan, et al.
Publicado: (2017)